Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceImmunity

AHCC

AHCC is a standardized shiitake mycelium extract with one genuinely interesting result: a small randomized trial in which it cleared persistent high-risk HPV infection far more often than placebo. That finding is promising and unreplicated, and it is the only supplement claim here with trial support — the broader "immune booster" and cancer marketing goes well beyond it.

What the science says

  • Clears persistent high-risk HPV infection Limited evidence

    In a randomized, double-blind, placebo-controlled study of 50 women with persistent high-risk HPV, 3 g/day of AHCC for up to six months produced HPV-negative status in roughly 63% of the treatment group versus about 11% on placebo, alongside changes in interferon-beta and NK activity. This is a striking effect size, but from a single small trial at one center with the manufacturer supplying product — it needs independent replication before it should change practice.

  • Modulates innate immune function Limited evidence

    The proposed mechanism, developed across preclinical and early human work, is that AHCC's partially acylated alpha-1,4-glucan fraction increases NK cell activity, dendritic cell numbers and interferon signaling. Human immunological data are limited to small studies with variable endpoints, and "increases NK activity" is a laboratory measure, not a demonstrated clinical benefit.

  • Improves outcomes or tolerability in cancer Limited evidence

    AHCC's cancer reputation rests largely on Japanese observational and open-label work — for example post-resection hepatocellular carcinoma cohorts — plus animal studies of chemotherapy side effects. Registered randomized trials, including a phase II protocol in resectable pancreatic cancer, are how this will actually be settled; until they report, AHCC should not be presented as cancer therapy or used in place of it.

  • Justifies its price versus ordinary mushroom extracts Limited evidence

    AHCC is a specific patented process (liquid-cultured Lentinula edodes mycelia, enzymatically treated to yield low-molecular-weight acylated alpha-glucans), not the beta-glucan-dominated profile of standard shiitake or reishi powders, so generic "mushroom complex" products are not substitutes. Equally, none of the trial evidence transfers to those cheaper products — you are paying for the one ingredient that was actually tested.

Dosage & safety

Studied doseThe HPV trials used 3 g/day (typically 3 x 1 g capsules on an empty stomach) for 3-6 months; some Japanese oncology protocols have used 3-6 g/day. Immune-parameter studies have used 1-3 g/day. At 3 g/day this is one of the more expensive supplements on the market, commonly over $2 per day.
SafetyGenerally well tolerated in trials, with mild GI effects — bloating, nausea, loose stools — and occasional headache or fatigue in the first weeks. AHCC has been shown in animal work to alter cytochrome P450 activity (notably CYP2D6), so caution is warranted with narrow-therapeutic-index drugs; a case-report-level interaction concern also exists with doxorubicin. Because it is marketed as an immune stimulant, people on immunosuppressants, transplant recipients, and those with autoimmune disease should discuss it with their clinician first. Not established in pregnancy or breastfeeding. Critically, persistent HPV requires ongoing cervical screening and colposcopy per guideline — a supplement does not replace surveillance or treatment of high-grade lesions.

Scientific references

Where to buy

American Biosciences, ImmPower® D3, AHCC® Plus Vitamin D3, 30 Vegetarian Capsules

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Immunity